**Labeled Indications**

- Contraception (104 mg per 0.65 mL and 150 mg/mL injection): Medroxyprogesterone acetate is used to prevent pregnancy in females of reproductive potential.

- Amenorrhea, secondary (tablet): Women experiencing amenorrhea due to hormonal imbalance and not because of organic pathologies such as fibroids and uterine cancer.

- Abnormal uterine bleeding (tablet): The drug is indicated for women experiencing abnormal bleeding due to hormonal imbalance and not because of organic pathologies such as fibroids and uterine cancer.

- Endometrial hyperplasia prevention (tablet): Medroxyprogesterone acetate is administered to non-hysterectomized postmenopausal patients receiving a daily oral dose of estrogen of 0.625 mg.

- Endometrial carcinoma (400 mg/mL injection or 100 mg tablet): In patients with inoperable, recurrent, and/or metastatic endometrial carcinoma, medroxyprogesterone acetate is used as adjunctive and/or palliative treatment.

- Endometriosis (104 mg/0.65 mL injection): Used in patients experiencing pain related to endometriosis.

**Off-Label Indications**

- Acute abnormal uterine bleeding

- Endometrial hyperplasia

- Hot flashes

- Paraphilia/hypersexuality